| | IL17RA, LINC01640 +2088 more | Copy number gain | See cases | |
| | LOC130067034, LOC130067035 +535 more | Copy number gain | See cases | |
| | LOC130067403, LOC130067404 +2088 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +798 more | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | ADORA2A, ADORA2A-AS1 +823 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Duplication | Schizophrenia | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +163 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +160 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +160 more | Copy number gain | See cases | GConflicting classifications of pathogenicity |
| | | Copy number gain | See cases | |
| | IGLV3-22, IGLV3-25 +160 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +157 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +124 more | Copy number gain | See cases | |
| | LOC130067187, LOC130067188 +556 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +84 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +81 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +81 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +80 more | Copy number gain | See cases | |
| | LOC130067094, LOC130067095 +80 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +80 more | Copy number gain | See cases | |
| | | Duplication | Schizophrenia | |
| | | Duplication | Schizophrenia | |
| | ADORA2A, ADORA2A-AS1 +74 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +76 more | Copy number gain | See cases | |
| | LOC130067120, LOC130067121 +76 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +70 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +76 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +74 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +74 more | Copy number gain | See cases | GConflicting classifications of pathogenicity |
| | ADORA2A, ADORA2A-AS1 +74 more | Copy number gain | See cases | |
| | DERL3, LOC111721701 +5 more | Copy number gain | See cases | |
| | ADORA2A, ADORA2A-AS1 +57 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Single nucleotide variant (non-coding transcript variant) | | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | MIF-related disorder | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | MIF-related disorder | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | MIF-related disorder | |
| | ADORA2A, C22orf15 +25 more | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | See cases | |
| | ADORA2A, C22orf15 +25 more | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | Chromosome 22q11.2 microduplication syndrome | |
| | | Duplication | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | Unilateral renal agenesis | |
| | | Copy number gain | Chromosome 22q11.2 microduplication syndrome | |
| | C22orf15, CHCHD10 +10 more | Deletion | Agammaglobulinemia 2, autosomal recessive | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | Generalized-onset seizure +1 more | |
| | | Copy number gain | not provided | |
| | | Duplication | not provided | |
| | | Duplication | Epilepsy +1 more | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | Cat eye syndrome +1 more | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Deletion | not provided | |
| | | Duplication | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | ADORA2A, C22orf15 +25 more | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |